Bristol-Myers Squibb To Pay $19.5M Over Abilify Marketing

Tweets by Amgen Bristol-Myers Squibb Co. will pay $19.5 million to settle allegations that it promoted the anti-psychotic drug Abilify for unapproved uses and misled doctors about its dangers, it was announced Thursday.

California Attorney General Kamala Harris announced the settlement of a state business code violations lawsuit on the same day that the final agreement was received by a San Diego court.
MORE ON THIS TOPIC